NattoPharma releases Q3 2020 Trading Statement: Continued strong growth in the third quarter
Oslo, Norway (11 November 2020) Followed by a very strong first half of 2020, NattoPharma increased revenues in the third quarter by 54%, bringing the YTD growth to 72% compared to the same period in 2019. YTD Adjusted EBITDA came in at NOK 22.9 million equal to a margin of 15.0%. Performance highlights for Q3 2020 (Q3 2019 in brackets) · Operating revenue of NOK 47.5m (NOK 30.9m) · Adjusted EBITDA of NOK 6.1m (NOK 3.2m) · Adjusted Total OpeX as % of Revenue 30.3% (32.5%) · Cash flow from Operating Activities of NOK 21.2m (NOK 8.8m) · Inventory balance of NOK 45.0 (